Role of Paraoxonase-1 in the Protection of Hydrogen Sulfide-Donating Sildenafil (ACS6) Against Homocysteine-Induced Neurotoxicity

[1]  A. Durmuş,et al.  Effects of sildenafil citrate on torsion/detorsion-induced changes in red blood cell and plasma lipid peroxidation, antioxidants, and blood hematology of male rats. , 2011, European journal of obstetrics, gynecology, and reproductive biology.

[2]  Jia-min Zhuo,et al.  Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? , 2011, Trends in pharmacological sciences.

[3]  A. Sparatore,et al.  ACS6, a Hydrogen sulfide-donating derivative of sildenafil, inhibits homocysteine-induced apoptosis by preservation of mitochondrial function , 2011, Medical Gas Research.

[4]  Xue Hua,et al.  Homocysteine effects on brain volumes mapped in 732 elderly individuals , 2011, Neuroreport.

[5]  J. Golmard,et al.  Folate and Homocysteine in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease or Dementia: A Case Control Study , 2011, European Neurology.

[6]  Xiao-Qing Tang,et al.  Inhibition of Hydrogen Sulfide Generation Contributes to 1-Methy-4-Phenylpyridinium Ion-Induced Neurotoxicity , 2011, Neurotoxicity Research.

[7]  Zhi-Sheng Jiang,et al.  Hydrogen sulfide antagonizes homocysteine-induced neurotoxicity in PC12 cells , 2010, Neuroscience Research.

[8]  B. Winblad,et al.  Homocysteine and holotranscobalamin and the risk of Alzheimer disease , 2010, Neurology.

[9]  A. Haghparast,et al.  Curcumin exerts neuroprotective effects against homocysteine intracerebroventricular injection-induced cognitive impairment and oxidative stress in rat brain. , 2010, Journal of medicinal food.

[10]  Y. H. Kwon,et al.  Protective effect of isoflavones against homocysteine-mediated neuronal degeneration in SH-SY5Y cells , 2010, Amino Acids.

[11]  P. Wong,et al.  Hydrogen sulfide: A novel signaling molecule in the central nervous system , 2010, Neurochemistry International.

[12]  W. Gordon-Krajcer,et al.  Homocysteine-induced acute excitotoxicity in cerebellar granule cells in vitro is accompanied by PP2A-mediated dephosphorylation of tau , 2009, Neurochemistry International.

[13]  Y. Terayama,et al.  Homocysteine May Contribute to Pathogenesis of RNA Damage in Brains with Alzheimer’s Disease , 2009, Neurodegenerative Diseases.

[14]  J. Poirier,et al.  Involvement of paraoxonase 1 genetic variants in Alzheimer’s disease neuropathology , 2009, The European journal of neuroscience.

[15]  D. Ryglewicz,et al.  Paraoxonase activity and dementia , 2009, Journal of the Neurological Sciences.

[16]  Zhi-Sheng Jiang,et al.  Hydrogen sulfide inhibits MPP(+)-induced apoptosis in PC12 cells. , 2009, Life sciences.

[17]  W. A. Gool,et al.  Hyperhomocysteinemia and Alzheimer's disease: A systematic review. , 2009, Archives of gerontology and geriatrics.

[18]  P. Goldschmidt-Clermont,et al.  The paraoxonase gene family and atherosclerosis , 2009, Current atherosclerosis reports.

[19]  G. Angelini,et al.  H2S‐donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G , 2008, British journal of pharmacology.

[20]  Hyang-Ki Cho,et al.  Synergistic induction of ER stress by homocysteine and beta-amyloid in SH-SY5Y cells. , 2008, The Journal of nutritional biochemistry.

[21]  S. Loureiro,et al.  Homocysteine activates calcium-mediated cell signaling mechanisms targeting the cytoskeleton in rat hippocampus , 2008, International Journal of Developmental Neuroscience.

[22]  J. Joven,et al.  Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. , 2008, Free radical biology & medicine.

[23]  T. Hayek,et al.  Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties. , 2008, Free radical biology & medicine.

[24]  P. Moore,et al.  Characterization of a Novel, Water-Soluble Hydrogen Sulfide–Releasing Molecule (GYY4137): New Insights Into the Biology of Hydrogen Sulfide , 2008, Circulation.

[25]  S. Vehid,et al.  Levels of paraoxonase, an index of antioxidant defense, in patients with active sarcoidosis , 2008, Current medical research and opinion.

[26]  C. Grimm,et al.  Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for neuroprotection , 2008, BMC Genomics.

[27]  S. W. Lee,et al.  Hydrogen sulfide: Neurochemistry and neurobiology , 2008, Neurochemistry International.

[28]  A. Camproux,et al.  Homocysteine threshold value based on cystathionine beta synthase and paraoxonase 1 activities in mice , 2007, European journal of clinical investigation.

[29]  C. Szabó.  Hydrogen sulphide and its therapeutic potential , 2007, Nature Reviews Drug Discovery.

[30]  Byung-Hwan Lee,et al.  Neuroprotective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus , 2007, Brain Research.

[31]  C. Oldreive,et al.  Neurotoxic effects of homocysteine on cerebellar Purkinje neurons in vitro , 2007, Neuroscience Letters.

[32]  Lingyun Wu,et al.  Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. , 2006, Biochemical and biophysical research communications.

[33]  Shelly C. Lu,et al.  S-adenosylmethionine stabilizes cystathionine beta-synthase and modulates redox capacity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Aviram,et al.  Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences , 2005, Current opinion in lipidology.

[35]  L. Whalley,et al.  Enhanced hippocampal long-term potentiation in rats after chronic exposure to homocysteine , 2005, Neuroscience Letters.

[36]  B. Halliwell,et al.  The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite ‘scavenger’? , 2004, Journal of neurochemistry.

[37]  N. D. De Santo,et al.  Homocysteine and oxidative stress , 2003, Amino Acids.

[38]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[39]  C. Masters,et al.  Homocysteine potentiates copper‐ and amyloid beta peptide‐mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's‐type neurodegenerative pathways , 2001, Journal of neurochemistry.

[40]  B. La Du,et al.  Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. , 1999, Free radical biology & medicine.

[41]  S. Butcher,et al.  Synaptosomal plasma membrane transport of excitatory sulphur amino acid transmitter candidates: Kinetic characterisation and analysis of carrier specificity , 1992, Journal of neuroscience research.

[42]  A. Chait,et al.  The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. , 1987, The Journal of biological chemistry.

[43]  B. Ames,et al.  Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. , 1983, Analytical biochemistry.

[44]  D. Shih,et al.  Metabolism and neurotoxicity of homocysteine thiolactone in mice: evidence for a protective role of paraoxonase 1. , 2012, Journal of Alzheimer's disease : JAD.

[45]  R. Chang,et al.  Neuroprotective effects of polysaccharides from wolfberry, the fruits of Lycium barbarum, against homocysteine-induced toxicity in rat cortical neurons. , 2010, Journal of Alzheimer's disease : JAD.

[46]  Hieronim Jakubowski,et al.  The role of paraoxonase 1 in the detoxification of homocysteine thiolactone. , 2010, Advances in experimental medicine and biology.

[47]  J. Chen,et al.  Effect of hydrogen sulphide on beta-amyloid-induced damage in PC12 cells. , 2008, Clinical and experimental pharmacology & physiology.

[48]  G. Karikas,et al.  Serum homocysteine levels and paraoxonase 1 activity in preschool aged children in Greece , 2006, Clinical chemistry and laboratory medicine.

[49]  R. Barouki,et al.  Inverse correlation between phenylacetate hydrolase activity of the serum PON1 protein and homocysteinemia in humans , 2005, Thrombosis and Haemostasis.

[50]  D. Ashline,et al.  Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress. , 2001, Journal of neurochemistry.

[51]  R. Wolfe,et al.  Homocysteine metabolism. , 1999, Annual review of nutrition.